Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -10.44 is 1291% below its 5-year average of 0.88, near the low end of its 5-year range (-13.61–6.33).
As of the fiscal period ended Wednesday, December 31, 2025. 186.81% below its 12-month average of -3.64.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
-10.44
EARNINGS PER SHARE (EPS) AVG TTM
-3.64
EARNINGS PER SHARE (EPS) AVG 3Y
-0.05
EARNINGS PER SHARE (EPS) AVG 5Y
0.88
EARNINGS PER SHARE (EPS) AVG 10Y
1.49
EARNINGS PER SHARE (EPS) AVG 15Y
1.91
EARNINGS PER SHARE (EPS) AVG 20Y
1.48
CURRENT VS TTM AVG
-186.81%
CURRENT VS 3Y AVG
-18881.82%
CURRENT VS 5Y AVG
-1290.87%
CURRENT VS 10Y AVG
-799.82%
CURRENT VS 15Y AVG
-647.83%
CURRENT VS 20Y AVG
-804.65%
Centene Corp.
Market Cap
$30.74B
Earnings Per Share (EPS)
-10.44
TTM Avg
-3.64
3Y Avg
-0.05
5Y Avg
0.88
Market Cap
$30.72B
Earnings Per Share (EPS)
3.45
TTM Avg
4.46
3Y Avg
4.05
5Y Avg
4.25
Market Cap
$29.99B
Earnings Per Share (EPS)
151.44
TTM Avg
10.02
3Y Avg
12.26
5Y Avg
14.06
Market Cap
$28.62B
Earnings Per Share (EPS)
44.51
TTM Avg
41.42
3Y Avg
39.43
5Y Avg
36.04
Market Cap
$27.44B
Earnings Per Share (EPS)
5.92
TTM Avg
0.10
3Y Avg
-3.15
5Y Avg
-4.54
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Centene Corp. (CNC) | $30.74B | -10.44 | -3.64 | -0.05 | 0.88 |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.72B | 3.45 | 4.46 | 4.05 | 4.25 |
| ResMed Inc. (RMD)vs › | $30.60B | 10.34 | 8.25 | 6.99 | 5.92 |
| Biogen Inc. (BIIB)vs › | $29.99B | 151.44 | 10.02 | 12.26 | 14.06 |
| DexCom, Inc. (DXCM)vs › | $32.20B | 2.53 | 1.80 | 1.48 | 1.30 |
| Zoetis Inc. (ZTS)vs › | $32.40B | 6.03 | 5.75 | 5.27 | 4.80 |
| Mettler-Toledo International Inc. (MTD)vs › | $28.62B | 44.51 | 41.42 | 39.43 | 36.04 |
| Medline Inc. (MDLN)vs › | $33.22B | 1.21 | 1.48 | 0.80 | 0.80 |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $27.44B | 5.92 | 0.10 | -3.15 | -4.54 |
| Quest Diagnostics Incorporated (DGX)vs › | $25.72B | 9.42 | 8.33 | 8.09 | 9.83 |
Trailing EPS (TTM)
$-10.44
Forward EPS (Est.)
$4.59
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -13.61 |
| 2024-12-31 | 6.33 |
| 2023-12-31 | 4.97 |
| 2022-12-31 | 2.09 |
| 2021-12-31 | 2.31 |
| 2020-12-31 | 3.17 |
| 2019-12-31 | 3.19 |
| 2018-12-31 | 2.31 |
| 2017-12-31 | 2.40 |
| 2016-12-31 | 1.76 |
| 2015-12-31 | 1.49 |
| 2014-12-31 | 1.17 |
| 2013-12-31 | 0.76 |
| 2012-12-31 | 0.01 |
| 2011-12-31 | 0.56 |
| 2010-12-31 | 0.49 |
| 2009-12-31 | 0.49 |
| 2008-12-31 | 0.48 |
| 2007-12-31 | 0.42 |
| 2006-12-31 | -0.25 |
| 2005-12-31 | 0.33 |
| 2004-12-31 | 0.27 |
| 2003-12-31 | 0.23 |
| 2002-12-31 | 0.21 |
| 2001-12-31 | 0.75 |
| 2000-12-31 | 0.67 |
| 1999-12-31 | -0.92 |
